Skip to main content
OpenTrials
Completed

NCT Number: NCT05904002

Effect of Incentive Spirometery on Asthmatic Pregnant Women

The purpose of this study is to determine the effect of the incentive spirometer on asthma during pregnancy.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Asthmatic Asthma Bronchial Diseases Female Urogenital Diseases and Pregnancy Complications Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Lung Diseases Lung Diseases, Obstructive Pregnancy Complications Pregnant With Complication Respiratory Hypersensitivity Respiratory Tract Diseases Urogenital Diseases

Age range

30 year–40 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Outpatient clinic faculty of physical therapy cairo university

Dokki, Egypt

About this study

This study will provide an evidence basis for obstetricians and physical therapist for women's health about the effect of spirometry on asthma during pregnancy.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

The patients will have the following criteria:

  • Their age will range from 30 to40years old.
  • Body mass index (BMI) will range from 25-29.9 kg/m2.
  • All patients will be clinically and medically stable.

Exclusion criteria

Patients will be excluded from the study if they have the following:

  • Diabetes mellitus.
  • Severe hypertension.
  • Neurological and neuromuscular disorders.
  • Blindness.
  • Developed moderate and severe degree of pleural effusion.
  • Cardiovascular instability.
  • Chronic chest disease.

Treatment and study plan

pulmicort inhaler

Drug

Each woman in both groups (A&B) will receive pulmicort inhaler on needs.

Incentive spirometer treatment

Device

Each patient in group B will be instructed about the effects of incentive spirometer to gain their cooperation during the study course.

Primary outcomes

  1. Assessing the change in lung functions

    Time frame: at baseline and after 6 weeks of intervention

    The spirometer will be used for assessment of lung functions including total lung capacity (TLC) (litre), which is the most widely used functional index in the asthma follow up.

  2. Assessing the change in symptoms of asthma

    Time frame: at baseline and after 6 weeks of intervention

    The Asthma Control Test provides a numerical score to help you and your healthcare provider determine if your asthma symptoms are well controlled. Take this test if you are 12 years or older. Share the score with your healthcare provider.

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Important dates

Study start
2020
Primary completion
2021
Study completion
2022
First posted
Jun 15, 2023
Registry last updated
Jun 15, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.